Clinigen Group (CLIN)

Sector:

Food Pharmacy Retail

Index:

FTSE AIM 50

869.50p
   
  • Change Today:
      13.00p
  • 52 Week High: 1,069.00
  • 52 Week Low: 721.00
  • Currency: UK Pounds
  • Shares Issued: 132.85m
  • Volume: 137,796
  • Market Cap: £1,155.12m
  • Beta: 0.81

Thursday broker round-up

By Caoimhe Toman

Date: Thursday 19 Sep 2019

LONDON (ShareCast) - (Sharecast News) - Ferguson: RBC Capital Markets downgrades to underperform with a target price of 5,100p.

Kingfisher: UBS reiterates sell with a target price of 180p.

British Land: Barclays reiterates hold with a target price of 600p.

Beazley: Peel Hunt reiterates reduce with a target price of 460p.

Clinigen Group: Peel Hunt reiterates buy with a target price of 1,390p.

Petropavlovsk: Canaccord upgrades to buy with a target price of 16p.

Quixant: Berenberg downgrades to hold with a target price of 175p.

Xeros Technology: Berenberg reiterates buy with a target price of 20p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Clinigen Group Market Data

Currency UK Pounds
Share Price 869.50p
Change Today 13.00p
% Change 1.52 %
52 Week High 1,069.00
52 Week Low 721.00
Volume 137,796
Shares Issued 132.85m
Market Cap £1,155.12m
Beta 0.81

Clinigen Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.68% below the market average54.68% below the market average54.68% below the market average54.68% below the market average54.68% below the market average
7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average
Price Trend
36.19% below the market average36.19% below the market average36.19% below the market average36.19% below the market average36.19% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Income
45.92% below the market average45.92% below the market average45.92% below the market average45.92% below the market average45.92% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
47.03% above the market average47.03% above the market average47.03% above the market average47.03% above the market average47.03% above the market average
69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average

What The Brokers Say

Strong Buy 6
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Clinigen Group Dividends

  Latest Previous
  Final Interim
Ex-Div 07-Nov-19 21-Mar-19
Paid 29-Nov-19 12-Apr-19
Amount 4.75p 1.95p

Trades for 15-Nov-2019

Time Volume / Share Price
16:37 50,000 @ 872.96p
16:35 26,279 @ 869.50p
16:29 44 @ 872.00p
16:29 300 @ 873.50p
16:29 300 @ 873.50p

Clinigen Group Key Personnel

CEO Shaun Edward Chilton

Top of Page